PureTech News

Press releases
Press Releases - 2022-12-07
PureTech Founded Entity Vor Bio Announces First AML Patient Successfully Transplanted with its Investigational Trem-cel (VOR33) and Tolerated Mylotarg™
Press Releases - 2022-11-30
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-310
PureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech's Glyph™ Platform
Press Releases - 2022-11-17
PureTech to Present at Two Upcoming Investor Conferences
Press Releases - 2022-11-09
PureTech to Present at the Jefferies London Healthcare Conference
Press Releases - 2022-11-02
PureTech Founded Entity Gelesis Announces Two Presentations at ObesityWeek 2022
Press Releases - 2022-11-01
PureTech to Present at the Credit Suisse 31st Annual Healthcare Conference
Press Releases - 2022-10-11
Statement regarding termination of discussions with Nektar Therapeutics (“Nektar”)”
Press Releases - 2022-10-06
Statement Regarding Recent Press Speculation
Press Releases - 2022-09-08
PureTech to Present at the Morgan Stanley Global Healthcare Conference
Press Releases - 2022-09-05
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-100
PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting Design of Dose-Ranging Trial in Idiopathic Pulmonary Fibrosis (IPF) at European Respiratory Society International Congress 2022
Displaying 21 - 30 of 342

Sign up for email alerts

To receive news as it is released, please sign up.